COSCIENS Biopharma (CSCI) News Today $3.16 +0.02 (+0.48%) As of 03:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsTrendsBuy This Stock CSCI Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period COSCIENS Biopharma Inc (USA) trading halted, news pendingAugust 15, 2025 | msn.comCOSCIENS Biopharma Inc (USA) trading resumesAugust 14, 2025 | msn.comCOSCIENS Biopharma Reports Q2 2025 Results and Strategic Delisting from NasdaqAugust 14, 2025 | msn.comCOSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives UpdateAugust 14, 2025 | financialpost.comFCOSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives UpdateAugust 14, 2025 | globenewswire.comCOSCIENS Biopharma Announces Results of Virtual 2025 Meeting of ShareholdersJune 30, 2025 | globenewswire.comCSCI COSCIENS Biopharma Inc.June 1, 2025 | seekingalpha.comCOSCIENS Biopharma Inc. Reconstitutes Board for Benefit of ShareholdersMay 30, 2025 | financialpost.comFCOSCIENS Biopharma Inc. Reconstitutes Board for Benefit of ShareholdersMay 30, 2025 | finance.yahoo.comCosciens Biopharma announces receipt of Goodwood intended director nominationsMay 27, 2025 | finance.yahoo.comCOSCIENS Biopharma Receives Director Nominations Ahead of Shareholder MeetingMay 27, 2025 | tipranks.comCOSCIENS Biopharma Receives Director Nominations from GoodwoodMay 26, 2025 | tipranks.comCOSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for ...May 26, 2025 | gurufocus.comCOSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of ShareholdersMay 26, 2025 | financialpost.comFCOSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for ...May 26, 2025 | gurufocus.comCOSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of ShareholdersMay 26, 2025 | globenewswire.comGoodwood to Nominate New Directors for COSCIENS Biopharma Inc.May 23, 2025 | finance.yahoo.comCOSCIENS Biopharma reports key corporate updatesMay 21, 2025 | uk.investing.comCOSCIENS Biopharma Completes Merger with Ceapro and Restructures GovernanceMay 20, 2025 | tipranks.comCosciens Biopharma: Top 10 Undervalued Biotechnology Industry Stocks (CSCI)May 19, 2025 | theglobeandmail.comCosciens Biopharma Inc CSCIMay 15, 2025 | morningstar.comMCOSCIENS Biopharma Reports Q1 2025 Financial Results Amid Strategic ShiftsMay 13, 2025 | tipranks.comCOSCIENS Biopharma Reports Q1 2025 Results and Strategic UpdatesMay 13, 2025 | tipranks.comCOSCIENS Biopharma Inc. Transitions to Pure-Play Natural Products Company, Announces Phase 2 Clinical Trial Advancements and New CEO AppointmentMay 13, 2025 | quiverquant.comQCOSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate UpdateMay 13, 2025 | globenewswire.comCOSCIENS Biopharma Inc. (CSCI)May 10, 2025 | finance.yahoo.comCosciens Biopharma appoints Biehn as CEOApril 14, 2025 | markets.businessinsider.comCOSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn ...April 14, 2025 | gurufocus.comCOSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn ...April 14, 2025 | gurufocus.comCOSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive OfficerApril 14, 2025 | financialpost.comFCOSCIENS Biopharma Reports Revenue Growth and Strategic RepositioningApril 9, 2025 | tipranks.comCOSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate UpdateApril 9, 2025 | globenewswire.comCOSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate UpdateApril 9, 2025 | globenewswire.comCOSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade OrderApril 1, 2025 | financialpost.comFCOSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade OrderApril 1, 2025 | globenewswire.comCOSCIENS Biopharma Faces Potential Delay in Year-End Filings Due to Merger ComplexitiesMarch 19, 2025 | tipranks.comCOSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting DocumentsMarch 19, 2025 | financialpost.comFCOSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting DocumentsMarch 19, 2025 | gurufocus.comCOSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting DocumentsMarch 19, 2025 | globenewswire.comCOSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory ProductMarch 13, 2025 | financialpost.comFCOSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory ProductMarch 13, 2025 | globenewswire.comCOSCIENS Biopharma Focuses on Natural Product GrowthDecember 23, 2024 | tipranks.comCOSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline PrioritizationDecember 23, 2024 | financialpost.comFCOSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline PrioritizationDecember 23, 2024 | financialpost.comFCOSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline PrioritizationDecember 23, 2024 | investing.comCOSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline PrioritizationDecember 23, 2024 | globenewswire.comCOSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development ProgramsNovember 12, 2024 | globenewswire.comCOSCIENS Biopharma Announces Change to Board of DirectorsOctober 8, 2024 | globenewswire.comCOSCIENS Biopharma Announces Appointment of Pierre Labbé as DirectorOctober 1, 2024 | globenewswire.comCOSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development ProgramsSeptember 23, 2024 | globenewswire.com Get COSCIENS Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CSCI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CSCI Media Mentions By Week CSCI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CSCI News Sentiment▼1.880.99▲Average Medical News Sentiment CSCI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CSCI Articles This Week▼11▲CSCI Articles Average Week Get the Latest News and Ratings for CSCI and Related Stocks Enter your email address to receive the latest news and analysts' ratings for COSCIENS Biopharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies KLTO News Today RNXT News Today BTAI News Today ESLA News Today EGRX News Today SCYX News Today CLSD News Today SNYR News Today AKTX News Today MURA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CSCI) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding COSCIENS Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share COSCIENS Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access